Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background And Purpose: Cerebral microbleeds (CMBs) are a marker of small vessel diseases, including hypertensive arteriopathy and cerebral amyloid angiopathy, and may be associated with cognitive impairment. The relationship between CMBs and cognitive function in ischemic cerebrovascular disease remains uncertain. We, therefore, investigated the cognitive impact of CMBs in a cohort of patients with ischemic stroke or transient ischemic attack.
Methods: All patients underwent detailed and comprehensive neuropsychological testing and standardized MRI, including fluid attenuation inversion recovery, T1, T2, and gradient-recalled echo T2*-weighted sequences. CMBs, white matter changes, lacunes, and territorial cortical infarcts (defined by standardized criteria) were identified, and associations with cognition assessed.
Results: Three hundred twenty patients with a diagnosis of ischemic stroke or transient ischemic attack were included. Of these, 72 (22.5%) had at least 1 CMB. Of all the cognitive domains tested, only executive impairment was more prevalent in patients with CMBs than without (38% versus 25%; P=0.039). In univariate analysis, the presence of strictly lobar (but not deep) CMBs was associated with executive impairment (odds ratio, 2.49; 95% confidence interval, 1.16-5.36; P=0.019). In adjusted multivariate analyses, the presence (OR, 2.34; 95% confidence interval, 1.08-5.09; P=0.031) and number (OR, 1.33; 95% confidence interval, 1.04-1.69; P=0.022) of strictly lobar CMBs were significantly associated with executive impairment. CMBs were not associated with impairment in other cognitive domains.
Conclusions: Strictly lobar CMBs are independently associated with executive dysfunction in patients with ischemic stroke or transient ischemic attack. Our findings suggest that a microangiopathy related to strictly lobar CMBs (eg, cerebral amyloid angiopathy) contributes to cognitive impairment in this population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/STROKEAHA.111.000245 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between cerebral microbleeds and cognition in a memory clinic population.
J Prev Alzheimers Dis
August 2025
Department of Neuropsychiatry, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea; Department of Psychiatry, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea; Institute of Human Behavioral Medicine, Se
Background: The cognitive consequences of cerebral microbleeds (CMBs) in memory clinic population with a diverse cognitive spectrum remain unclear.
Objectives: This study aimed to investigate how CMBs at different locations are associated with cognitive performance in a memory clinic population and whether these associations are independent of related small vessel disease (SVD) markers.
Design: A cross-sectional study.
Typical distribution of hypertensive cerebral microbleed: a matched case-control study using primary aldosteronism.
Hypertens Res
August 2025
Department of Neurology, Saga University, Saga, Japan.
The topographical distribution of non-strictly lobar cerebral microbleed (CMB) is considered as a neuroimaging marker of hypertensive arteriopathy, but pathological evidence remains insufficient. This case-control study assessed patients with primary aldosteronism (PA), a leading cause of secondary hypertension, to characterize the CMB distribution features of typical hypertensive arteriopathy. A PA group (n = 11) and an age-matched non-hypertensive control group (n = 22) were classified into subgroups based on the presence of any CMB or no CMB using paramagnetic-sensitive MRI.
View Article and Find Full Text PDFIncreased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration.
J Neurol Neurosurg Psychiatry
August 2025
Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Background: Patients with chronic kidney disease are at increased risk of stroke and frequently have cerebral microbleeds. Whether such patients also encounter an increased risk of recurrent stroke has not been firmly established. We aimed to determine whether impaired kidney function is associated with the risk of recurrent stroke, and microbleed presence, distribution and severity.
View Article and Find Full Text PDFUnveiling the characteristics of lobar-predominant cerebral microbleeds in Fabry disease.
J Formos Med Assoc
April 2025
Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address:
Background And Objectives: Fabry disease (FD) is a multisystem lysosomal storage disorder with central nervous system and cardiac involvement. Although FD is associated with varying severity of white matter hyperintensity (WMH) on brain magnetic resonance imaging (MRI), cerebral microbleeds (CMBs) have been less studied. This study examined CMBs in FD and identified their association with clinical parameters.
View Article and Find Full Text PDFCharacterizing the underlying microangiopathy of deep cerebellar intracerebral hemorrhage.
J Neurol
January 2025
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Introduction: While cerebral amyloid angiopathy is likely responsible for intracerebral hemorrhage (ICH) occurring in superficial (grey matter, vermis) cerebellar locations, it is unclear whether hypertensive arteriopathy (HA), the other major cerebral small vessel disease (cSVD), is associated with cerebellar ICH (cICH) in deep (white matter, deep nuclei, cerebellar peduncle) regions. We tested the hypothesis that HA-associated neuroimaging markers are significantly associated with deep cICH compared to superficial cICH.
Patients And Methods: Brain MRI scans from consecutive non-traumatic cICH patients admitted to a referral center were analyzed for cSVD markers.